Associations of urinary phthalate metabolites with risk of papillary thyroid cancer

Chemosphere. 2020 Feb:241:125093. doi: 10.1016/j.chemosphere.2019.125093. Epub 2019 Oct 11.

Abstract

Some studies have revealed thyrotoxicity of phthalates; however, associations of phthalate exposure with papillary thyroid cancer (PTC) remain unclear. We conducted a pair-matching case-control study of 111 PTC cases and 111 age- and sex-matched non-PTC controls to examine associations between urinary concentrations of phthalate metabolites and PTC. Phthalate metabolites were determined in fasting urine specimens by ultra-performance liquid chromatography - tandem mass spectrometry (UPLC-MS/MS). After adjusting for potential confounders and other phthalate metabolites, the concentrations of the sum of di (2-ethylhexly) phthalate (DEHP) metabolites in urine were positively associated with PTC [odds ratio (OR) = 5.35; 95% confidence interval (CI): 1.61-17.83], suggesting the effect of phthalates exposure on PTC development. The findings require confirmation.

Keywords: Case-control study; Phthalate; Thyroid cancer; Urinary metabolites.

MeSH terms

  • Adult
  • Case-Control Studies
  • Chromatography, Liquid
  • Diethylhexyl Phthalate / urine
  • Environmental Exposure / adverse effects
  • Environmental Exposure / analysis
  • Female
  • Humans
  • Male
  • Middle Aged
  • Odds Ratio
  • Phthalic Acids / urine*
  • Tandem Mass Spectrometry
  • Thyroid Cancer, Papillary / chemically induced*
  • Thyroid Cancer, Papillary / urine
  • Thyroid Neoplasms / chemically induced*
  • Thyroid Neoplasms / urine

Substances

  • Phthalic Acids
  • phthalic acid
  • Diethylhexyl Phthalate